The results showed that PDLIM2 expression was significantly associated with immune checkpoint expression in most tumor types, although there was no significant relationship in ACC, esophageal carcinoma, LIHC, uterine carcinosarcoma, and uveal melanoma (Fig. 8). This evidence concerns the gene PDLIM2 and carcinoma of esophagus.